Clinical Trial Update: Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide [Phase 2]

View source ↗

Summary

Phase II study of irinotecan plus temozolomide in adults with primary malignant glioma, including glioblastoma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Camptosar (irinotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED